Factors influencing inclusion of patients with malignancies in clinical trials.
about
NatHER: protocol for systematic evaluation of trends in survival among patients with HER2-positive advanced breast cancerSPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trialsDeveloping a survey of barriers and facilitators to recruitment in randomized controlled trials.Recruitment barriers in a randomized controlled trial from the physicians' perspective: a postal survey.Resolving Rivalries and Realigning Goals: Challenges of Clinical and Research Multiteam Systems.Promoting Factors and Barriers to Participation in Early Phase Clinical Trials: Patients Perspectives.Decision Making in the PICU: An Examination of Factors Influencing Participation Decisions in Phase III Randomized Clinical TrialsImpact of prior cancer on eligibility for lung cancer clinical trials.Identification of accrual barriers onto breast cancer prevention clinical trials: a case-control studyBarriers to recruitment of rural patients in cancer clinical trials.Clinicians' attitudes towards clinical trials of cancer therapyEffect of prior cancer on outcomes in advanced lung cancer: implications for clinical trial eligibility and accrual.Predictors for clinical trial participation in the rare lung disease lymphangioleiomyomatosis.Chemotherapy-related hospitalization among community cancer center patientsA pilot study of a culturally targeted video intervention to increase participation of African American patients in cancer clinical trials.Power of an effective clinical conversation: improving accrual onto clinical trialsReasons why patients fail screening in Indian breast cancer trialsConsent timing and experience: modifiable factors that may influence interest in clinical researchOncologists' recommendations of clinical trial participation to patientsOlder age impacts radiotherapy-related outcomes in soft tissue sarcoma.Impact of the National Cancer Institute Community Cancer Centers Program on Clinical Trial and Related Activities at a Community Cancer Center in Rural NebraskaAn institutional strategy to increase minority recruitment to therapeutic trials.Early Phase Clinical Trials: Referral Barriers and Promoters among Physicians.Influence of clinical communication on patients' decision making on participation in clinical trials.Enrollment of patients to clinical trials in haematological cancer in New South Wales: current status, perceived barriers and opportunities for improvement.Disparities in cancer clinical trials: an analysis of comprehensive cancer control plans.Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer.Motivators to participation in medical trials: the application of social and personal categorization.Time and Effort Required for Tissue Acquisition and Submission in Lung Cancer Clinical Trials.View of physicians on and barriers to patient enrollment in a multicenter clinical trial: experience in a Japanese rural area.Attitudes of small animal practitioners toward participation in veterinary clinical trials.Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity.The choice of whether to participate in a phase I clinical trial: increasing the awareness of patients with cancer. An exploratory study.Recruiting former melanoma patients via hospitals in comparison to office-based dermatologists in a register-based cohort study that required indirect contact.Identifying barriers to accrual in radiation oncology randomized trials.Barriers to Cancer Clinical Trial Participation Among Saudi Nationals: A Cross-Sectional Study.Is implementing screening for distress an efficient means to recruit patients to a psychological intervention trial?Impact of prior malignancy on outcomes of stage IV esophageal carcinoma: SEER based study.Barriers to non-small cell lung cancer trial eligibility.Barriers to participation in clinical trials: a physician survey.
P2860
Q26782856-3A594FC2-A97E-40E9-81AC-10E3C15323ABQ28710019-BE257965-8EBA-4291-A8D6-1A99DA7C7AF8Q30534385-39E1AA78-7526-49B9-A1FD-8AC412615C11Q33413991-4F2480A5-3AA7-44B0-BE98-F91ADD9A5B24Q33756587-85FF9D4C-9099-4DF0-99DD-4B1975C4F712Q33956979-874B426B-AEC6-4266-AAE5-35884DC5EFACQ34069207-5A71A1C3-C936-44BF-A298-DA6670398435Q34736086-76F5B4E5-8FA1-47A1-B73D-73C9804A8214Q34798608-D094EA51-D85A-42EE-B30E-599573B5F29FQ34974911-1FB53C2A-73FD-49AA-8DA5-4EB0D94E1DFAQ35006767-D5310C0B-E242-41A3-9F9B-3001D957C9C8Q35473988-6EA2597B-FFD7-454C-8A9D-F57664AFC7D3Q35531599-67CAC2FD-1B8A-48A5-866C-FC3C066D8245Q35584511-220389A5-4A00-4EB1-922D-5E9F380B3801Q35989988-55E96273-104C-46D3-8EAC-6661CABD1C3FQ36226289-0EA43925-AC41-42FA-B22D-B29DD5B4F08AQ36266597-E1E8ADD4-2319-4EB6-9AC4-B754B90E60EBQ36278436-402522FB-4B00-4DE1-B336-23309E96C698Q36470363-8DC79503-5757-4AC4-88C0-7BE945639DDEQ36680534-7DEF9CA7-B8C5-4C80-A00B-111579562537Q37157672-26FB1FC7-43A0-48E9-8728-334B79A0F953Q37170627-B2A9015B-3712-4004-9D14-F99CA8AD71B1Q37195671-D46793C8-AD23-4563-85A8-A0828AF65CF8Q37253723-84CE3F07-E89D-481E-B7E5-ADD9298D8DB5Q37394310-7B9A47C4-17F1-4BA9-B4EE-9769E9BA803FQ37414872-C3EE3523-2674-4A82-834F-0030CEF2BFFBQ37564081-06F9A6DB-7411-4CB3-98A0-06C17928E5CDQ38077582-C5A3D644-A4F9-4DD3-88A4-B1C262A914FFQ38374064-B4163D4B-D257-44B7-9EDE-1D49350D5BAFQ38429284-441D3898-381B-422B-809D-A3E564706AF1Q39078175-625F6690-20A0-4191-826E-FB8F22121A06Q45065271-8E66DB39-8772-4A29-86C8-7E4B6524D682Q46587807-B5523AE1-791B-4EEA-A607-7213C68A7E11Q47113516-5F502778-75E7-4CE6-B223-9C41594B86F1Q47158489-D3D3B2A5-F953-408E-B098-8EDD8F7D52A5Q47686048-CF3789F3-03F9-48E2-865C-5DFE2F553DD8Q47875813-14ACFF45-747E-4DD5-BD29-89588318B1F5Q48277958-48E3D14C-2FD6-46E7-BBD0-9B8089DEC95EQ52562491-23774C02-9214-42AF-BAB6-14CBE55CA44BQ53826788-3F70C8E4-E1CA-46FC-9378-7164C176DD7B
P2860
Factors influencing inclusion of patients with malignancies in clinical trials.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Factors influencing inclusion of patients with malignancies in clinical trials.
@ast
Factors influencing inclusion of patients with malignancies in clinical trials.
@en
type
label
Factors influencing inclusion of patients with malignancies in clinical trials.
@ast
Factors influencing inclusion of patients with malignancies in clinical trials.
@en
prefLabel
Factors influencing inclusion of patients with malignancies in clinical trials.
@ast
Factors influencing inclusion of patients with malignancies in clinical trials.
@en
P2860
P50
P356
P1433
P1476
Factors influencing inclusion of patients with malignancies in clinical trials.
@en
P2093
Caroline Tournoux
P2860
P304
P356
10.1002/CNCR.21613
P407
P577
2006-01-01T00:00:00Z